Leukemia - Chronic T-Cell Lymphocytic

Doctors are working to learn more about T-cell leukemia, ways to prevent it, how to best treat it, and how to provide the best care to people diagnosed with this disease. The following areas of research may include new options for patients through clinical trials. Always talk with you doctor about the diagnostic and treatment options best for you.

New treatment combinations. New treatments are being tested in clinical trials, including new combinations of chemotherapy and immunotherapy. For ATLL, several new treatments are being studied including bortezomib (Velcade); arsenic trioxide (Trisenox); and daclizumab (Zenapax), an anti-IL2 antibody. Romidepsin is also being researched for patients with mycosis fungoides.

Supportive care. Clinical trials are underway to find better ways of reducing symptoms and side effects of current T-cell leukemia treatments in order to improve patients’ comfort and quality of life.

Learn more about common statistical terms used in cancer research.

Looking for More about Current Research?

If you would like additional information about the latest areas of research regarding leukemia, explore these related items:

• To find clinical trials specific to your diagnosis, talk with your doctor or search online clinical trial databases now.

• Review research announced at recent scientific meetings or in ASCO’s peer-reviewed journals.

• Read ASCO’s latest Clinical Cancer Advances report, which highlights top research findings over the past year.

Or, choose “Next” (below, right) to continue reading this detailed section.